Amphenol Corp SEC Filings

Amphenol (APH) insider transaction: An officer identified as President, CS Division reported an option exercise and same‑day sale on 10/29/2025. The filing shows an exercise of 80,000 stock options at an exercise price of $33.295 per share (code M), followed by an open market sale of 80,000 Class A Common shares (code S) at a $141.0366 weighted average price, with trades ranging from $141.00 to $141.1550.

Following these transactions, the filing lists 0 non‑derivative shares beneficially owned and 186,000 derivative securities (stock options) beneficially owned. The stock option series exercised was originally exercisable on 05/20/2022 and expires on 05/20/2031.

Amphenol (APH) reported an insider transaction by its President & CEO and Director on 10/28/2025. The filing shows a bona fide gift of 75,000 Class A Common shares (Code G), and an option exercise (Code M) for 75,000 shares at an exercise price of $22.3725 per share. Following these transactions, the reporting person directly owned 2,002,507 shares. Additional holdings include 864,177 shares held indirectly by the Norwitt Family Trust and 3,968 shares held directly through an IRA. The closing price on the gift date was $137.29.

Amphenol (APH): On 10/29/2025, Sr. VP, Secretary & General Counsel Lance E. D'Amico exercised stock options for 120,000 Class A shares at $22.5525 (code M) and sold 120,000 shares at a weighted average price of $140.0129 (code S), executed across trades ranging from $139.71 to $140.53.

Following these transactions, he directly owned 76,400 shares and indirectly held 25,000 shares via the Lance E. D'Amico 2025 GRAT #1. The exercised options were from a grant first exercisable on 05/21/2021 and expiring on 05/21/2030; 100,000 stock options remained beneficially owned.

The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 125,227,087 shares of Amphenol Corp (APH) common stock, representing 10.25% of the class as of 09/30/2025.

Vanguard reported 0 shares with sole voting power and 7,332,606 shares with shared voting power. It reported 113,675,172 shares with sole dispositive power and 11,551,915 shares with shared dispositive power. Vanguard certified the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

APH — Form 144 notice of proposed sale. A holder filed to sell 120,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $16,801,548.00. The issuer had 1,224,055,508 shares outstanding as of the notice. The approximate sale date is 10/29/2025.

The shares to be sold were acquired on 10/29/2025 via exercise of options under a registered plan, with payment in cash. In the past three months, related sales reported include 30,000 shares for $3,324,249.00 by LANCE E D'AMICO 2024 IRRV TRUST and 100,000 shares for $11,060,030.00 by LANCE D AMICO on 08/18/2025.

This notice states the seller does not know of undisclosed material adverse information.

Amphenol (APH): Shareholder files Form 144 notice to sell stock. A holder named William Doherty filed to sell up to 80,000 shares of Amphenol common stock through Morgan Stanley Smith Barney LLC on or about 10/29/2025. The filing lists an aggregate market value of $11,282,928 for the proposed sale and identifies the NYSE as the exchange.

The shares were acquired on 10/29/2025 via the exercise of options under a registered plan, paid in cash. The filing also reports recent activity over the past three months: 113,000 shares sold on 08/11/2025 for gross proceeds of $12,462,837.80 and 113,000 shares sold on 08/08/2025 for gross proceeds of $12,304,750.80.

Amphenol Corporation launched a primary debt offering of $7.5 billion in senior notes across seven tranches to help finance its planned $10.5 billion cash acquisition of CommScope’s Connectivity and Cable Solutions businesses. Tranches include $500 million floating-rate notes due 2027 at Compounded SOFR + 0.53%, plus fixed-rate notes: $750 million 3.800% due 2027, $750 million 3.900% due 2028, $1.0 billion 4.125% due 2030, $1.25 billion 4.400% due 2033, $1.6 billion 4.625% due 2036, and $1.65 billion 5.300% due 2055.

The company expects approximately $7,431.8 million in net proceeds, to be combined with cash on hand and potential borrowings under delayed draw term loans and/or its U.S. commercial paper program to fund the acquisition and related fees. The offering is not conditioned on closing the deal. If the acquisition is not completed by the specified date or is abandoned, all series are subject to a special mandatory redemption at 101% of principal plus accrued interest. The notes are unsecured senior obligations, include a 101% repurchase upon a Change of Control Repurchase Event, and settle on a T+10 basis.

Amphenol Corporation entered into an underwriting agreement to offer and sell multiple tranches of senior notes totaling $7.5 billion. The deal includes $500,000,000 floating rate notes due 2027, $750,000,000 notes due 2027, $750,000,000 notes due 2028, $1,000,000,000 notes due 2030, $1,250,000,000 notes due 2033, $1,600,000,000 notes due 2036, and $1,650,000,000 notes due 2055.

The closing of the offerings is expected on November 10, 2025, subject to the satisfaction of customary closing conditions. The company also announced the pricing of each series in a press release referenced as Exhibit 99.1. The agreement is filed as Exhibit 1.1 and tied to Registration Statement No. 333-270605.

Amphenol (APH) reported insider transactions by its HES Division President on 10/24/2025. The officer exercised stock options for 212,800 shares at $33.295 and 152,318 shares at $43.25, then sold the same amounts—212,800 and 152,318 shares—at a weighted average price of $134.6508.

The filing notes the sale price was executed in multiple trades ranging from $133.5000 to $136.8375. In addition, 80,000 shares were reported as gifted, with a closing price on the gift date of $133.82. Following these transactions, the officer directly beneficially owned 353,742 shares. Remaining option balances after the exercises were shown in Table II.